StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Trading Down 6.6 % Shares of BLCM stock opened at $0.07 on Friday. Bellicum Pharmaceuticals has a 12 month low of $0.06 and a […]
Related Keywords
United States , , Boxer Capital , Bellicum Pharmaceuticals Trading Down , Institutional Investors Weigh In On Bellicum Pharmaceuticals , Securities Exchange Commission , Bellicum Pharmaceuticals , Nasdaq , Bellicum Pharmaceuticals Inc , News Ratings For Bellicum Pharmaceuticals Daily , Free Report , Pharmaceuticals Trading Down , Get Free Report , Bellicum Pharmaceuticals Daily , Nasdaq Blcm , Blcm , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.